GTR Home > Tests > Search results - Neuroblastoma 3

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C2751681[DISCUI]

C Clinical test, R Research test

Showing 1 to 11 of 11 tests for 1 condition in 8 labs

CNeuroblastoma, susceptibility to, 3

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CHereditary Neuroblastoma via the ALK gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCentral Nervous System Hereditary Cancer Panel, Sequencing and Deletion/Duplication, 15 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (21)
Total targets (15)

CALK

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Conditions
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CNeuroblastoma (sequence analysis of ALK gene)

Lab: CGC Genetics Porto, Porto, Portugal
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CALK. Sequencing of the exons 21-28

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • E Sequence analysis of select exons

CALK. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CHereditary Cancer Syndrome: Sequencing Panel

Lab: Emory Genetics Laboratory Emory University Decatur, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (107)
Total targets (46)

CNeuroblastoma - ALK Known Point Mutation Analysis

Lab: Molecular Genetics Laboratory Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Conditions
Test targets
Methods
  • T Targeted variant analysis

CNeuroblastoma - ALK and PHOX2B Sequence Analysis

Lab: Molecular Genetics Laboratory Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNeuroblastoma - ALK Sequence Analysis

Lab: Molecular Genetics Laboratory Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 11 of 11 tests for 1 condition in 8 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.